Assessment of Emerging Biomarkers of Liver Injury in Human Subjects

The Effects of Heparins on the Liver: Application of Mechanistic Serum Biomarkers in a Randomized Study in Healthy Volunteers

(2012) A H Harrill et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Case Definition and Phenotype Standardization in Drug-Induced Liver Injury

(2011) G P Aithal et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Towards consensus practices to qualify safety biomarkers for use in early drug development

(2010) Frank D Sistare et al.   NATURE BIOTECHNOLOGY

Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity

(2009) M. Keskin et al.   INTERNAL MEDICINE JOURNAL

Measurement of serum paraoxonase-1 activity in the evaluation of liver function

(2009) Jordi Camps et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Factors Associated with Paraoxonase Genotypes and Activity in a Diverse, Young, Healthy Population: The Coronary Artery Risk Development in Young Adults (CARDIA) Study

(2008) B. Thyagarajan et al.   CLINICAL CHEMISTRY

The current state of serum biomarkers of hepatotoxicity

(2007) Josef Ozer et al.   TOXICOLOGY